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ecause of contact with 
patients, physicians readily 
appreciate that large-scale social 
forces—racism, gender inequality, 
poverty, political violence and war, 
and sometimes the very policies that 
address them—often determine who 
falls ill and who has access to care. 
For practitioners of public health, the 
social determinants of disease are even 
harder to disregard.
    Unfortunately, this awareness 
is seldom translated into formal 
frameworks that link social analysis 
to everyday clinical practice. One 
reason for this gap is that the holy 
grail of modern medicine remains 
the search for the molecular basis 
of disease. While the practical yield 
of such circumscribed inquiry has 
been enormous, exclusive focus 
on molecular-level phenomena 
has contributed to the increasing 
“desocialization” of scientiﬁ  c inquiry: 
a tendency to ask only biological 
questions about what are in fact   biosocial   
phenomena [1].
    Biosocial understandings of medical 
phenomena are urgently needed. 
All those involved in public health 
sense this, especially when they 
serve populations living in poverty. 
Social analysis, however rudimentary, 
occurs at the bedside, in the clinic, 
in ﬁ  eld sites, and in the margins of 
the biomedical literature. It is to be 
found, for example, in any signiﬁ  cant 
survey of adherence to therapy for 
chronic diseases [2,3] and in studies 
of what were once termed “social 
diseases” such as venereal disease 
and tuberculosis (TB) [4–8]. The 
emerging phenomenon of acquired 
resistance to antibiotics—including 
antibacterial, antiviral, and 
antiparasitic agents—is perforce a 
biosocial process, one which began 
less than a century ago as novel 
treatments were introduced [9]. 
Social analysis is heard in discussions 
about illnesses for which signiﬁ  cant 
environmental components are 
believed to exist, such as asthma and 
lead poisoning [10–15]. Can we speak 
of the “natural history” of any of these 
diseases without addressing social 
forces, including racism, pollution, 
poor housing, and poverty, that shape 
their course in both individuals and 
populations? Does our clinical practice 
acknowledge what we already know—
namely, that social and environmental 
forces will limit the effectiveness 
of our treatments? Asking these 
questions needs to be the beginning 
of a conversation within medicine and 
public health, rather than the end of 
one.
  Deﬁ  ning Structural Violence
    The term “structural violence” is one 
way of describing social arrangements 
that put individuals and populations 
in harm’s way (see Box 1) [16]. The 
arrangements are   structural   because 
they are embedded in the political and 
economic organization of our social 
world; they are   violent   because they 
cause injury to people (typically, not 
those responsible for perpetuating 
such inequalities). With few exceptions, 
clinicians are not trained to understand 
such social forces, nor are we trained 
to alter them. Yet it has long been clear 
that many medical and public health 
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  Box 1. What Is Structural 
Violence?
   Structural violence , a term coined 
by Johan Galtung and by liberation 
theologians during the 1960s, describes 
social structures—economic, political, 
legal, religious, and cultural—that stop 
individuals, groups, and societies from 
reaching their full potential [57]. In its 
general usage, the word   violence  often 
conveys a physical image; however, 
according to Galtung, it is the “avoidable 
impairment of fundamental human 
needs or…the impairment of human life, 
which lowers the actual degree to which 
someone is able to meet their needs 
below that which would otherwise be 
possible” [58]. Structural violence is often 
embedded in longstanding “ubiquitous 
social structures, normalized by stable 
institutions and regular experience” [59]. 
Because they seem so ordinary in our 
ways of understanding the world, they 
appear almost invisible. Disparate access 
to resources, political power, education, 
health care, and legal standing are just 
a few examples. The idea of   structural 
violence  is linked very closely to   social 
injustice  and the social machinery of 
oppression [16]. PLoS Medicine  |  www.plosmedicine.org 1687
interventions will fail if we are unable 
to understand the social determinants 
of disease [17,18].
    The good news is that such 
biosocial understandings are far more 
“actionable” than is widely recognized. 
There is already a vast and growing 
array of diagnostic and therapeutic 
tools born of scientiﬁ  c research; it is 
possible to use these tools in a manner 
informed by an understanding of 
structural violence and its impact on 
disease distribution and on every step 
of the process leading from diagnosis 
to effective care. This means working 
at multiple levels, from “distal” 
interventions—performed late in the 
process, when patients are already 
sick—to “proximal” interventions—
trying to prevent illness through efforts 
such as vaccination or improved water 
and housing quality.
    As with many other concepts, 
structural violence has its limitations 
[19]. Nevertheless, we seek to apply the 
concept to what remain the primary 
tasks of clinical medicine: preventing 
premature death and disability and 
improving the lives of those we care 
for. Using the concept of structural 
violence, we intend to begin, or revive, 
discussions about social forces beyond 
the control of our patients.
    These forces are not beyond the 
reach, however, of practitioners of 
medicine and public health. In this 
article, we describe examples of the 
impact of structural violence upon 
people living with HIV in the United 
States and in Rwanda. In both cases, 
we show that it is possible to address 
structural violence through structural 
interventions. We then draw general 
lessons from these examples for 
health professionals and policy makers 
worldwide.
    Delivering AIDS Care Equitably 
in the United States
    The distribution and outcome of 
chronic infectious diseases, such as 
HIV/AIDS, are so tightly linked to 
social arrangements that it is difﬁ  cult 
for clinicians treating these diseases to 
ignore social factors. Although AIDS 
is often considered a “social disease,” 
clinicians may have radically different 
understandings of what makes AIDS 
“social.” Many doctors have focused on 
the “behaviors” or “lifestyles” that place 
some at risk for HIV infection [20–23]. 
Yet risk has never been determined 
solely by individual behavior: 
susceptibility to infection and poor 
outcomes is aggravated by social factors 
such as poverty, gender inequality, 
and racism [24–26]. Unsurprisingly, 
in less than a decade AIDS became 
a disease that disproportionately 
affected America’s poor, many of 
whom engaged in “risk behaviors” at 
a far lower rate than others who were 
not at heightened risk of infection with 
sexually transmitted diseases [27–29].
      Factors affecting disease course.   
HIV attacks the immune system in 
only one way, but its course and 
outcome are shaped by social forces 
having little to do with the universal 
pathophysiology of the disease. From 
the outset of acute HIV infection to the 
endgame of recurrent opportunistic 
infections, disease course is determined 
by, to cite but a few obvious factors: 
(1) whether or not postexposure 
prophylaxis is available; (2) whether 
or not the steady decline in immune 
function is hastened by concurrent 
illness or malnutrition; (3) whether or 
not multiple HIV infections occur; (4) 
whether or not TB is prevalent in the 
surrounding environment; (5) whether 
or not prophylaxis for opportunistic 
infections is reliably available [30]; and 
(6) whether or not antiretroviral therapy 
(ART) is offered to all those needing it.
    Throughout the usually decade-
long process of HIV progression, 
detrimental social structures and 
constructs—structural violence—
have a profound inﬂ  uence on 
effective diagnosis, staging, and 
treatment of the disease and its 
associated pathologies. Each of these 
determinants of disease course and 
outcome is itself shaped by the very 
social forces that determine variable 
risk of infection.
    Although the variability of outcomes 
has been especially obvious in the 
era of effective therapy, it was so even 
before ART became widely available. 
In Baltimore in the early 1990s, Moore 
et al. showed that race was associated 
with the timely receipt of therapeutics: 
among patients infected with HIV, 
blacks were signiﬁ  cantly less likely 
than whites to have received ART or 
  Pneumocystis   pneumonia prophylaxis 
when they were ﬁ  rst referred to an 
HIV clinic, regardless of disease stage 
at the time of presentation [31]. 
The timeline from HIV infection 
to death was further shortened in 
situations where TB was the leading 
opportunistic infection, as it is in 
much of the poor world [32]. These 
fundamentally biosocial events call 
into question a “natural history” of 
HIV infection and AIDS.
DOI: 10.1371/journal.pmed.0030449.g001
  Figure 1.   Components of the Package for Prevention of Mother-to-Child Transmission of HIV 
Provided by Partners In Health/Inshuti Mu Buzima in Rwanda 
      Photo: Ophelia Dahl, Partners In Health 
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      Addressing disparities in HIV care.   
In an attempt to address these ethnic 
disparities in care, researchers and 
clinicians in Baltimore reported how 
racism and poverty—forms of structural 
violence, though they did not use these 
speciﬁ  c terms—were embodied [33,34] 
as excess mortality among African 
Americans without insurance. After 
documenting these disparities, these 
clinicians and researchers asked: what 
would happen if race and insurance 
status no longer determined who had 
access to the standard of care? 
    Their subsequent interventions 
were decidedly proximal: in addition 
to removing some of the obvious 
economic barriers at the point of 
care, the clinicians and researchers 
considered paying for transportation 
costs and other incentives as well 
as addressing comorbid conditions 
ranging from drug addiction to 
mental illness. They also implemented 
improvements in community-based 
care, conceived to make AIDS 
care more convenient and socially 
acceptable for patients. The goal was 
to make sure that nothing within the 
medical system or the surrounding 
community prevented poor and 
otherwise marginalized patients from 
receiving the standard of care.
    The results registered just a few 
years later were dramatic: racial, 
gender, injection-drug use, and 
socioeconomic disparities in outcomes 
largely disappeared within the study 
population [35]. In other words, 
these program improvements may not 
have dealt with the lack of national 
health insurance, and still less with 
the persistent problems of racism and 
urban poverty, but they did lessen the 
embodiment of social inequalities as 
premature death from AIDS. Similar 
work elsewhere has shown the ability 
of providers to lessen the impact of 
social inequalities on AIDS outcomes 
among the homeless, the addicted, the 
mentally ill, and prisoners [36–38].
    The program in Baltimore was 
improved in part by linking an 
understanding of social context to 
clinical services. The importance of 
such programs is underscored by the 
emergence of multidrug-resistant HIV 
in the United States [39]. Microbial 
acquisition of resistance to antibiotics, 
including antiretrovirals, is necessarily 
a biosocial phenomenon. Most 
microbes mutate when challenged with 
antibiotics; the rate of mutation may be 
hastened by imprudent use of antibiotics 
or by inadequate or interrupted therapy 
[40,41]. Although structural violence 
lessens both access and adherence to 
effective therapy, it is a rarely discussed 
contributor to epidemics of multidrug-
resistant HIV. In reality, it is impossible 
to understand the dynamics of drug-
resistant disease without understanding 
how structural violence is embodied 
at the community, individual, and 
microbial levels [9,42]. The lessons from 
Baltimore show us that by viewing access 
to care and adherence to treatment as 
structural issues requiring programmatic 
solutions, we can alter the very biology 
of HIV and the “natural history” of 
AIDS.
    Preventing Pediatric AIDS in 
Rwanda: Lessons from Rural Haiti
    The impact of structural violence 
is even more obvious in the world’s 
poorest countries and has profound 
implications for those seeking to 
provide clinical services there. Over the 
past year, working with the nonproﬁ  t 
organization Partners In Health (PIH), 
we have sought to address AIDS and 
TB in Africa, the world’s poorest and 
most heavily burdened continent. 
Speciﬁ  cally, we have transplanted and 
adapted the “PIH model” of care, 
which was designed in rural Haiti to 
prevent the embodiment of poverty 
and social inequalities as excess 
mortality due to AIDS, TB, malaria, and 
other diseases of poverty [43,44].
      The PIH model.   In some senses, 
the model is simple: clinical and 
community barriers to care are 
removed as diagnosis and treatment 
are declared a public good and made 
available free of charge to patients 
living in poverty. Furthermore, AIDS 
care is delivered not only in the 
conventional way at the clinic, but also 
within the villages in which our patients 
work and live.
    Each patient chooses an 
  accompagnateur  , usually a neighbor, 
trained to deliver drugs and other 
supportive care in the patient’s home. 
Using this model, we currently provide 
daily supervised ART to more than 
2,200 patients in rural Haiti. This 
model, with conventional clinic-based 
(distal) services complemented by 
home-based (more proximal) care, is 
deemed by some to be the world’s most 
effective way of removing structural 
barriers to quality care for AIDS and 
other chronic diseases. It is also a way 
of creating jobs in rural regions in great 
need of them. We have used a similar 
model in urban Peru [45,46], and in 
Boston, Massachusetts [37]. 
      The challenge of HIV in Rwanda.   
Rwanda presents unique challenges, 
but many barriers to care are quite 
similar to those seen in Haiti and other 
settings where social upheaval, poverty, 
and gender inequality decrease the 
effectiveness of distal services and of 
prevention efforts. Like Haiti, Rwanda 
is a densely populated, predominantly 
agrarian society. Although both 
countries have endured large-scale 
political violence, that which registered 
a decade ago in Rwanda due to war and 
genocide was unprecedented in scale. 
In the two rural districts of Rwanda in 
which the PIH model was introduced 
in May 2005, an estimated 60 percent 
of inhabitants are refugees, returning 
exiles, or recent settlers; not a single 
physician was present to serve 350,000 
people.
    AIDS has recently worsened this 
situation and is a leading cause of 
young adult death. In spite of the 
availability of signiﬁ  cant resources to 
treat complications of HIV infection 
in Africa, almost all patients enrolled 
on ART live in cities or towns. Indeed, 
some have noted that rapid treatment 
scale-up is likely to occur largely in 
urban settings, where infrastructure, 
though poor, is better than in rural 
regions [47]. The challenge, however, 
is to reach rural Africa, where fewer 
than ﬁ  ve percent of those who need 
ART receive it. Rural treatment scale-
up is far from impossible: less than a 
year after our program began in 2005, 
more than 1,500 rural Rwandans with 
AIDS were already enrolled in care 
using the PIH model.
    To deepen our discussion of 
interventions designed to counter 
structural violence, consider the 
prevention of mother-to-child 
transmission (MTCT) of HIV in 
rural Rwanda. Where clean water is 
unavailable and HIV prevalence is 
high, the policy of universal breast-
feeding—driven by the desire to reduce 
diarrhea-related mortality—leads to 
increased transmission of the virus to 
infants, even when ART is offered. We 
knew from our experience in Haiti that 
we could reduce rates of MTCT from as 
high as 25 to 40 percent to as low as two 
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percent. We knew that such a dramatic 
reduction could be made possible by: 
(1) providing combination ART to the 
mother during pregnancy; (2) enabling 
formula-feeding and close follow-up 
of infants; and (3) launching potable 
water projects within the catchment 
area—in even the most difﬁ  cult 
regions, where electricity is scarce, food 
insecurity widespread, and health and 
sanitation infrastructure rudimentary at 
best [48].
    Although our pilot project in 
Rwanda is only a year old, its feasibility 
is almost certain. In the ﬁ  rst six 
months of operation, we screened 
for HIV infection more than 31,000 
persons in the two districts in which 
we work. Without exception, pregnant 
women found to be infected with HIV 
expressed interest in ART to prevent 
MTCT, and all requested assistance not 
only with procuring infant formula, but 
also with the means to boil water and to 
store the formula safely (Figure 1).
    Our distal intervention is to provide 
ART to all women in the catchment 
area with the help of   accompagnateurs  . 
More proximal interventions include 
the distribution of kerosene stoves, 
kerosene, bottles, and infant formula; 
we also provide food aid and housing 
assistance when possible. Already, we 
are seeing a lowering of HIV infection 
rates amongst newborns, and we 
believe that, as the program becomes 
well established and services become 
available earlier during the course of 
pregnancy, rates of MTCT will continue 
to decline.
    Unsurprisingly, opposition to the 
PIH model did not come from rural 
Rwandan women living with HIV. 
Rather, we faced the most resistance 
to this approach from local and global 
health policy makers who continued 
to promote universal breast-feeding, a 
policy which made eminent sense prior 
to the advent of HIV. Instead of trying 
to overcome programmatic barriers, 
the experts argued that formula-
feeding was simply not feasible in rural 
Rwanda and that HIV-related stigma 
would prevent women from enrolling 
in such projects.
    The examples of Rwanda and Haiti 
have shown us that, to date, there is 
little reason to believe that thoughtful 
structural interventions will fail to 
improve HIV prevention and treatment 
outcomes. Any failure is more likely 
to be due to programmatic shortfalls 
than to stigma or to non-compliance 
on the part of the patients enrolled in 
the program. Structural interventions 
of the sort described here remove the 
onus of adherence from vulnerable 
patients and place it squarely on the 
health system and on providers.
  Incorporating  Structural 
Interventions in Medicine 
and Public Health
    If structural violence is often a major 
determinant of the distribution 
and outcome of disease, why is it 
or a similar concept not in wider 
circulation in medicine and public 
health, especially now that our 
interventions can radically alter clinical 
outcomes? One reason is that medical 
professionals are not trained to make 
structural interventions. Physicians 
can rightly note that structural 
interventions are “not our job.” Yet, 
since structural interventions might 
arguably have a greater impact on 
disease control than do conventional 
clinical interventions, we would do well 
to pay heed to them.
    Acknowledging and addressing 
structural impediments, however, 
should never be the sole focus of our 
work. For decades, those who study 
the determinants of disease have 
known that social or structural forces 
account for most epidemic disease. 
But truisms such as “poverty is the root 
cause of tuberculosis” have not led us 
very far. While we do not yet have a 
curative prescription for poverty, we 
do know how to cure TB. Those who 
argue that focusing solely on economic 
development will in time wipe out 
tuberculosis may be correct, but en 
route toward this utopia the body count 
will remain high if care is not taken to 
diagnose and treat the sick. The same 
holds true for other diseases of poverty. 
Clean water and sanitation will prevent 
cases of typhoid fever, but those who 
fall ill need antibiotics; clean water 
comes too late for them.
    The debate about whether to focus 
on proximal versus distal interventions, 
or similar debates about how best to use 
scarce resources, is as old as medicine 
itself. But there is little compelling 
evidence that we must make such 
either/or choices: distal and proximal 
interventions are complementary, not 
competing. International public health 
is rife with false debates along precisely 
these lines, and the list of impossible 
choices facing those who work among 
the destitute sick seems endless. In 
reality, there is no good way to tackle 
the health crisis in Africa when the 
scant resources previously available are 
so bitterly contested; thus is structural 
violence perpetuated at a time in which 
science and medicine continue to yield 
truly miraculous tools. Without an 
equity plan to bring these tools to bear 
on the health problems of the destitute, 
these debates will continue to waste 
precious time [49].
      The lessons of Baltimore, Haiti, 
and Rwanda.   What are the lessons 
that can be drawn from the examples 
of successful structural interventions 
in the diverse settings of Baltimore, 
rural Haiti, and rural Rwanda? First, 
we have seen that it is possible to 
decrease the extent to which social 
inequalities become embodied 
as health disparities. While some 
interventions are straightforward, we 
also have to recognize that there is an 
enormous ﬂ  aw in the dominant model 
of medical care: as long as medical 
services are sold as commodities, they 
will remain available only to those who 
can purchase them. National health 
insurance and other social safety 
nets, including those that guarantee 
primary education, food security, and 
clean water, are important because 
they promise rights, rather than 
commodities, to citizens. The lack of 
these social and economic rights is 
fundamental to the perpetuation of 
structural violence [50].
    Second, we have learned that 
proximal interventions, seemingly quite 
remote from the practice of clinical 
medicine, can also lessen premature 
morbidity and mortality. To put this 
in sociological terms, interventions 
that increase the agency of the poor 
will lessen their risk of HIV. Similarly, 
it is not possible to have an honest 
discussion of alcoholism among Native 
Americans [51], or crack cocaine 
addiction among African Americans 
[52], without discussing the history of 
genocide and slavery in North America. 
Again, such commentary is often seen 
as extraneous in medical and public 
 Medical  professionals 
are not trained to make 
structural interventions. 
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health circles, where discussions 
of substance abuse are curiously 
desocialized, viewed as personal and 
psychological problems rather than 
societal ones. Here, too, structural 
violence is perpetuated through 
analytic omission.
    Third, we have seen that structural 
interventions can have an enormous 
impact on outcomes, even in the face 
of cost-effectiveness analyses and the 
ﬂ  awed policies of international bodies. 
Taking the components of the distal 
interventions already underway in 
Rwanda—infant formula, clean water, 
fuel, and so forth—it is possible to go 
further and describe more proximal 
interventions to improve access to 
each component of the project. These 
would include, of course, legislation 
to promote generic medications, 
improved distribution networks for 
ART and infant formula, clean-water 
campaigns, and the development of 
alternative fuels. More proximally 
still, they would include enhancing 
agricultural production; creating 
new jobs outside of the agricultural 
sector; addressing gender inequality 
through legislation about land tenure 
and political representation [53]; and 
promoting adult literacy.
    These are not the tasks for which 
clinicians were trained, but they are 
central to the struggle to reduce 
premature suffering and death. The 
importance of structural interventions 
for the future of health care means 
that practitioners of medicine and 
public health must make common 
cause with others who are trained to 
intervene more proximally. Sometimes 
public health crises, such as the AIDS 
pandemic in Africa, can lead to bold 
and speciﬁ  c interventions, such as the 
campaign to provide AIDS prevention 
and care as a public good [54]. When 
linked to more structural interventions, 
such ostensibly speciﬁ  c campaigns can 
help to trigger a “virtuous social cycle” 
that promises to shift the burden of 
pathology away from children and 
young adults—a major victory in the 
struggle to lessen structural violence.
  Conclusions
    Pioneers of modern public health 
during the nineteenth century, such 
as Rudolph Virchow, understood 
that epidemic disease and dismal 
life expectancies were tightly linked 
to social conditions [55,56]. Such 
leaders might not have employed 
the term “structural violence,” but 
they were well aware of its toll and 
argued compellingly for proximal 
interventions: education, basic 
sanitation, land reform, sovereignty, 
and an end to political oppression. 
These interventions are no less needed 
now that we have better distal tools, 
including vaccines, diagnostics, and 
a large armamentarium of effective 
therapeutics.
    It does not matter what we call it: 
structural violence remains a high-
ranking cause of premature death and 
disability. We can begin to address this 
by “resocializing” our understanding of 
disease distribution and outcome. Even 
new diseases such as AIDS have quickly 
become diseases of the poor, and the 
development of effective therapies may 
have a perverse effect if we are unable 
to use them where they are needed 
most. By insisting that our services be 
delivered equitably, even physicians 
who work on the distal interventions 
characteristic of clinical medicine have 
much to contribute to reducing the 
toll of structural violence. The poor 
are the natural constituents of public 
health, and physicians, as Virchow 
argued, are the natural attorneys of the 
poor. In this struggle, equity in health 
care   is   our responsibility. Only when 
we link our efforts to those of others 
committed to initiating virtuous social 
cycles can we expect a future in which 
medicine attains its noblest goals.   
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